Bhagirathbhai Dholaria, MBBS
Assistant Professor of Medicine, Department of Medicine
Adoptive cellular therapy (CAR-T)
Stem cell transplantation
Acute and chronic leukemias
Dr. Dholaria’s area of specialization is in the treatment of hematological malignancies and stem cell transplantation. His primary field of research is in the use of adoptive cellular therapies for the treatment of relapsed lymphoid and plasma cell malignancies. He has conducted studies investigating the outcomes of non- Hodgkin lymphoma patients undergoing chimeric antigen receptor T-cell (CAR-T) therapies. He is involved in translational research investigating the biomarkers of CAR T-cell therapy associated toxicities. He has also conducted several observational studies utilizing cancer registries to study outcomes of mature T-cell lymphoma patients and presented his findings in national meetings. He has won ASCO Conquer Cancer Foundation Merit award for his work.